Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the questions I get more than any other is, “Jonathan, how do you ...

This biotech has a powerful growth story, but one competitive threat could reshape the entire investment case before the ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

One small investment offers big benefits for Nvidia.

Vertex Pharmaceuticals is buying an endocrine treatment specialist for $10 billion.

Michael Yee, UBS biotech analyst, joins 'The Exchange' to discuss Yee's thoughts on biotech stocks, what's driving the ...

Biotech is the story at midday Friday, and it’s not a pretty one for shareholders who chased the sector’s monster 2026 run.

It has been a banner year for biotech buyouts, and these are two of the prime targets.

AI-assisted drug discovery isn't just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it's no mystery as to why many wish to be underweight in ...

Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse ...